NACDD is working with CDC’s Division of Cancer Prevention and Control to foster innovative public health approaches to cancer prevention. Building on past work, the purpose of this five-year project is to develop resources that will empower public health practitioners and community leaders to implement evidence-based strategies to reduce cancer risk in their communities by making it easier for people to reduce exposure to carcinogens and adopt healthy behaviors where they live, work, learn, and play.
(photo credit: https://www.pedbikeimages.org / NYCDOT)
Webinars
Complete Streets Webinar – July 22, 2019
Supporting Evidence
Resources
July 23, 2020 Webinar: Supporting Family Caregivers in America: Collaborative Opportunities for State, Local, Tribal and Territorial Health Departments
Webinar attendees were ask to complete a brief evaluation of the webinar. The results of those evaluations and a profile of attendees are included in this report.
Resources
Literature
Earlier in this five-year project, a CPAL strategic planning meeting led to the identification of four areas of focus:
A variety of activities have supported these workgroups during years 3-5, including SME interviews, a literature search, webinars, and briefs. The below resources are reflective of the combined activities from years 3, 4, and 5. More information about the previous work of the CPAL workgroup is available on the CDC website.
ACEs are common. Approximately 61% of adults surveyed across 25 states reported that they had experienced at least one type of ACE, and nearly 1 in 6 reported they had experienced four or more types of ACEs. Preventing ACEs could potentially reduce a large number of health conditions. Prolonged stress, or toxic stress, can affect neurological development. Children growing up with toxic stress may have difficulty forming healthy and stable relationships and serve as the basis for intergenerational transmission. (Centers for Disease Control and Prevention, Division of Injury Prevention and Control).
Associated Materials:
Associated Materials:
This site includes a systematic review of the literature to create a map of available evidence on the literature from 2020-2021. The purpose of the original review was to characterize the current state of the literature around social determinants of health and cancer in AIAN populations. This site also includes results of webinars and listening sessions with tribal elders and leaders. Read the report, Frameworks for Indigenous Evaluation: A Literature Review & Annotated Bibliography
Listening Session: Cancer Prevention Research Priorities and Dissemination
In partnership with the International Association for Indigenous Aging, NACDD convened a listening session to hear from select leaders in American Indian health about Cancer Prevention Research Among American Indian and Alaska Native Populations. The listening session discussed research priorities and dissemination.
Mainstream models and approaches to research and engagement can be a poor fit for tribes and Alaska Native communities and people. Existing Indigenous principles and approaches to research are unique and differ from traditional Western approaches. Read the listening session summary to learn more.
In collaboration with the CDC Cancer Prevention Across the Lifespan workgroup, NACDD is collaborating with the Lowell Center for Sustainable Products at the University of Massachusetts Lowell to present a series of webinars.
Learn more: https://www.uml.edu/Research/Lowell-Center/Chemicals-Materials-Products/Sustainable-Products/
Associated Materials:
PowerPoint slides
Working with Kognito, a health simulation company, and Westat, a research and analysis firm, NACDD is exploring innovative ways for healthcare providers to communicate complex health information about early onset breast cancer and breast health to women younger than 45 years of age who are making decisions about their care. The objective is development of two role-play conversations with virtual humans, one for providers for educational purposes and another for women under 45 years of age who have questions about their risk factors for breast cancer.